3FQ9 | Hormone | date | Jan 07, 2009 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Design Of An Insulin Analog With Enhanced Receptor-Binding Selectivity. Rationale, Structure, And Therapeutic Implicat | ||||||||||||||
authors | M.Zhao, Z.L.Wan, L.Whittaker, B.Xu, N.Phillips, P.Katsoyannis, J.W M.A.Weiss | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Insulin Chain: A, C Synonym: Insulin A Chain Engineered: Yes Mutation: Yes |
Synthetic: Yes Other_details: Biosynthetic Sequence Based On Human Insulin | ||||||||||||||
Molecule: Insulin Chain: B, D Synonym: Insulin B Chain Engineered: Yes |
Synthetic: Yes Other_details: Biosynthetic Sequence Based On Human Insulin | ||||||||||||||
symmetry | Space Group: H 3 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.35 Å | ||||||||||||
ligand | DAB, DAL, ZN | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications., Zhao M, Wan ZL, Whittaker L, Xu B, Phillips NB, Katsoyannis PG, Ismail-Beigi F, Whittaker J, Weiss MA, J Biol Chem. 2009 Nov 13;284(46):32178-87. Epub 2009 Sep 22. PMID:19773552 |
Data retrieval |
View 3FQ9 in 3D |
Visual 3D analysis of 3FQ9 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 3FQ9 |
Movements, Movies and Images |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |